The Department of Pharmacology at the Penn State College of Medicine has chosen to integrate the Stabilizor T1 system into its proteomic workflows.
Based on heat inactivation technology, Stabilizor T1 stabilises tissue from the crucial moment of sampling, permanently eliminating the activity of degradative enzymes without the use of additives.
Professor Freeman, of the Penn State College of Medicine's Department of Pharmacology at the Hershey Center for Applied Research, said: 'In our research facility, we are devoted to biomarker development to provide tools for more efficient drug development efforts and as clinical diagnostics.
'We are always concerned about post-mortem sample degradation, which has the potential to significantly affect analytical results.
'Denator's rapid heat inactivation technology allows us to stabilise tissues instantly and maintain that stability throughout our proteomic and genomic workflows.
'This will be an important tool for ensuring sample integrity and providing the clearest picture of the molecular basis of biological processes.'
